How to Buy Mentari Therapeutics Stock
Mentari Therapeutics Inc
InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids.
Mentari Therapeutics stock last closed at $12.20, down 23.75% from the previous day, and has decreased 24.69% in one year. It has overperformed other stocks in the Biotechnology industry by 0.72 percentage points. Mentari Therapeutics stock is currently +112.17% from its 52-week low of $5.75, and -47.64% from its 52-week high of $23.30.
At the moment, there are 549,374 shares of MTRI outstanding. The market cap of MTRI is $6.70M. In the last 24 hours, 57,000 MTRI shares were traded.
How to Buy Mentari Therapeutics Stock
Not sure how to invest in Mentari Therapeutics stock? Here's how.
- Figure out where to buy Mentari Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Mentari Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your method of payment and add your details.
- Evaluate Mentari Therapeutics stock: The Mentari Therapeutics ticker symbol is MTRI. Is Mentari Therapeutics stock a good investment? Should you buy shares of MTRI? How do MTRI's underlying business fundamentals look? Do top analysts think Mentari Therapeutics is a good buy? Why has MTRI's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if MTRI is a good stock to buy).
- Execute your MTRI purchase: Decide if you will purchase MTRI shares at the current market price or use a limit order to purchase MTRI stock at a specific price.
- Keep tabs on your MTRI investment: Create a watchlist to the latest updates on your investment in Mentari Therapeutics shares.
Step 1: Figure out where to buy Mentari Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy MTRI shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Tech to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal details so you are able to buy MTRI today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open your new trading account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've opened your account on our top ranked stock trading app, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details depositing funds into your new brokerage account.
Step 4: Evaluate Mentari Therapeutics stock
Once you have figured out the best place to buy Mentari Therapeutics stock, it's important to research their stock prior to buying, so you can comprehend the risk and upside.
Mentari Therapeutics shares data
MTRI Due Diligence Score
WallStreetZen was designed to help average investors do better fundamental analysis in less time.
You can view all of the due diligence checks on MTRI's stock page.
Is MTRI stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge MTRI's intrinsic value.
You can access more valuation analysis on MTRI's stock here.
MTRI Financials at a glance
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the MTRI balance sheet.
Failed Financial Due Diligence Checks:
- MTRI profit margin has gone down from -738.6% to -1,657.7% in the past year.
- Total MTRI debt is still negative.
- MTRI has $1.13M in cash and short term investments. This is not sufficient to cover its annual cash burn of $8.18M.
- MTRI has cash burn of 8175822. It does not have enough cash and short-term investments to cover this.
- MTRI debt to equity ratio of -2.09 is negative.
- There are more short-term liabilities than short-term assets on the MTRI balance sheet.
Is it a good time to buy Mentari Therapeutics stock, according to analysts?
Out of 3 Equities analysts who give ratings on MTRI, the consensus analyst rating on Mentari Therapeutics is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Mentari Therapeutics stock forecast page.
Metrics for Advanced MTRI Traders
MTRI Performance Numbers
Last year, MTRI revenue was $820.19k. During the past 4 year, MTRI's revenue has increased by -12.67% per year. This was slower than the Biotechnology industry average of 28.52%.
Dive into MTRI's earnings and revenue performance here.
Are MTRI executives and large shareholders buying or selling the stock?
In the past year, insiders at MTRI have bought more shares than they have sold.
Adar1 Capital Management LLC, 10% Owner of MTRI, was the latest MTRI insider to buy. They bought $34,570.80 worth of MTRI stock on Nov 5, 2026.
Get more info about who owns MTRI stock here.
Does MTRI provide a stable income stream?
No, Mentari Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about MTRI?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your MTRI purchase
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a particular price limit, use a limit order.
Press the Open button and your broker will place the order.
If you require additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your MTRI investment
Now that you own some MTRI stock, you'll want to stay up-to-date on your new investment.
Add MTRI to a watchlist to keep track of your MTRI stock.
MTRI Feed
How to Buy Stock in Mentari Therapeutics
To reiterate, here are the 6 steps to buy stock in Mentari Therapeutics:
- Figure out where to buy Mentari Therapeutics stock
- Open your brokerage account
- Fund your brokerage account
- Evaluate Mentari Therapeutics stock
- Execute your MTRI purchase
- Keep tabs on your MTRI investment
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Mentari Therapeutics, get started below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.